menu search

Biogen and eisai strengthen lead in alzheimer's drug race. the stocks are rising.

Shares in the pharmaceutical companies rose after the publication of a paper detailing the apparent ben...

November 30, 2022, 5:11 am

Revisiting tracon pharmaceuticals

Today, we look back in on clinical stage developmental firm TRACON pharmaceuticals for the first time s...

November 30, 2022, 1:43 am

Medgene therapeutics publishes preclinical data demonstrating riv-8’s ability to overcome t cell exhaustion in the journal science advances

RIV-8 is a breakthrough technology to address T cell exhaustion GAITHERSBURG, Md., Nov. 29, 2022 (GLOBE NEWSWIRE) — MedGene Therapeutics, Inc. (MedG...

November 29, 2022, 10:00 pm

Biopharma co. trades to new 52-week high

Source: Streetwise Reports (11/28/22) Shares of Axsome Therapeutics Inc. traded to a new 52-week high after the company reported its AXS-05 successful...

November 29, 2022, 9:23 pm

Pharma giants take interest in acquiring horizon therapeutics

Drugmaker Horizon Therapeutics PLC is fielding takeover interest, according to people familiar with the matter, as large ...

November 29, 2022, 4:45 pm

Horizon therapeutics fields takeover interest from pharma giants

The drugmaker recently had a market value close to $18 billion as big pharmaceutical companies rely on ...

November 29, 2022, 4:21 pm

Regeneron pharmaceuticals, inc. (regn) 5th annual evercore isi healthconx conference (transcript)

Regeneron pharmaceuticals, Inc. (NASDAQ:REGN ) 5th Annual Evercore ISI HealthCONx Conference November 2...

November 29, 2022, 2:50 pm

Why is otonomy (otic) stock up 97% today?

Otonomy (NASDAQ: OTIC ) stock is on the move Tuesday despite a lack of news from the biopharmaceutical ...

November 29, 2022, 12:27 pm

Arrowhead pharmaceuticals surges after hinting at a midstage win in liver disease

Arrowhead provided a bullish update for its midstage liver disease treatment on Monday, pushing ARWR stock to rocket Tuesday. The post Arrowhead ...

November 29, 2022, 12:01 pm

Rocket pharmaceuticals: 2 regulatory filings in 2023 could propel it higher

A Rocket pharmaceuticals, Inc. regulatory filing to the FDA of LV RP-L201 for Leukocyte Adhesion Defici...

November 29, 2022, 10:50 am

Vertex pharmaceuticals: growth outside of cystic fibrosis critical for additional value creation

Vertex reported strong results in the third quarter, driven by growth in ex-U.S. markets. The cystic fibrosis franchise will soon peak due to very hig...

November 29, 2022, 9:07 am

Bristol myers squibb: share price growth in 2022 best for a decade - but 2023 could better it

Bristol Myers Squibb is a pharmaceutical powerhouse after its Celgene acquisition. The company's revenu...

November 29, 2022, 7:30 am

Arrowhead pharmaceuticals, inc. (arwr) q4 2022 earnings call transcript

Arrowhead pharmaceuticals, Inc. (NASDAQ:ARWR ) Q4 2022 Earnings Conference Call November 28, 2022 4:30 ...

November 28, 2022, 8:44 pm

Shareholder alert: pomerantz law firm reminds shareholders with losses on their investment in eiger biopharmaceuticals, inc., of class action lawsuit and upcoming deadline – eigr

NEW YORK, Nov. 28, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP announces that a class action lawsuit has been filed against Eiger Bio...

November 28, 2022, 7:17 pm

Rallying merck stock flashing historically bullish signal

A week after announcing its acquisition of Imago Biosciences (IMGO), things are looking up for pharmaceutical<...

November 28, 2022, 1:59 pm

After plunging 35.3% in 4 weeks, here's why the trend might reverse for armata pharmaceuticals, inc. (armp)

Armata pharmaceuticals, Inc. (ARMP) has become technically an oversold stock now, which implies exhaust...

November 28, 2022, 11:17 am

Pfizer invites public to view and listen to webcast of pfizer discussion at healthcare conference

NEW YORK--( BUSINESS WIRE )--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a discussion with Ang...

November 28, 2022, 10:00 am

Zynerba pharmaceuticals' zygel shows meaningful behavioral symptom treatment progress in fragile x patients in phase 3 trial

Zynerba pharmaceuticals Inc (NASDAQ:ZYNE) announced that Fragile X patients treated with Zygel showed a...

November 28, 2022, 9:45 am

Voyageur pharmaceuticals completes production testing of smoothx; begins scale-up for canadian imaging market

Voyageur pharmaceuticals Ltd (TSX-V:VM, OTC:VYYRF) said it has completed the production test batch of i...

November 28, 2022, 9:11 am

Jazz pharmaceuticals to present data demonstrating advancements in epilepsy outcomes at the 2022 american epilepsy society annual meeting

Data from six abstracts to be presented, including new long-term Phase 3 results and two real-world analyses of U.S. caregiver-reported seizure and no...

November 28, 2022, 8:09 am


Search within

Pages Search Results: